Michael Virata
Overview
Explore the profile of Michael Virata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, et al.
Clin Infect Dis
. 2024 Nov;
PMID: 39492696
Background: Guidelines recommend annual anal cytology-based squamous cell carcinoma of anus (SCCA) screening for men who have sex with men (MSM) with HIV aged ≥35 years (eligible population). Recommended threshold...
2.
Womack J, Leblanc M, Sager A, Zaets L, Maisto S, Garcia A, et al.
AIDS Behav
. 2024 Oct;
29(2):482-496.
PMID: 39465468
Among persons with HIV (PWH), unhealthy alcohol use and polypharmacy contribute to bothersome symptoms (e.g., fatigue, dizziness, memory loss). However, effective risk communication targeting these associations is challenging. The HIV...
3.
Masood D, Ren L, Nguyen C, Brundu F, Zheng L, Zhao Y, et al.
Genome Biol
. 2024 Jun;
25(1):163.
PMID: 38902799
Background: Copy number variation (CNV) is a key genetic characteristic for cancer diagnostics and can be used as a biomarker for the selection of therapeutic treatments. Using data sets established...
4.
Strong S, Oldfield B, Berg J, Cole C, Biegacki E, Ogbuagu O, et al.
Prev Med Rep
. 2024 Jan;
37:102553.
PMID: 38282665
Unhealthy alcohol use is a common, often unaddressed behavior associated with increased risk for acquisition of HIV and may also be associated with decreased adherence to oral pre-exposure prophylaxis (PrEP)...
5.
Gleeson S, Zapata H, Bathgate M, Emu B, Frederick J, Friedland G, et al.
Clin Infect Dis
. 2023 Apr;
77(5):703-710.
PMID: 37078888
In response to longstanding healthcare inequities unmasked by the Coronavirus Disease 2019 pandemic, the infectious diseases (ID) section at the Yale School of Medicine designed and implemented a pilot curriculum...
6.
Kahn P, Ying X, Virata M, Magahis P, Li S, Mathis W
JAMA Netw Open
. 2023 Apr;
6(4):e237873.
PMID: 37027158
No abstract available.
7.
Wickersham J, Meyer J, Shenoi S, Altice F, Barakat L, Virata M, et al.
Front Med (Lausanne)
. 2022 Jul;
9:886936.
PMID: 35847816
Background: Approximately 215 million Americans have been fully vaccinated for COVID-19, representing over 65% of the total population. People with HIV (PWH) may be more susceptible to COVID-19 infection or...
8.
Morford K, Muvvala S, Chan P, Cornman D, Doernberg M, Porter E, et al.
J Subst Abuse Treat
. 2022 Mar;
139:108767.
PMID: 35341613
Background: While substance use disorders (SUD) disproportionately impact people with HIV (PWH), HIV clinics inconsistently provide evidence-based medications for addiction treatment (MAT). Patient receptivity to MAT is critical to enhance...
9.
Shrestha R, Meyer J, Shenoi S, Khati A, Altice F, Mistler C, et al.
Vaccines (Basel)
. 2022 Mar;
10(3).
PMID: 35335054
Introduction: Scaling up vaccination against COVID-19 is central to controlling the COVID-19 epidemic in the United States. Several vaccines are now approved for the prevention of COVID-19, but public concerns...
10.
Hysell K, Yusuf R, Barakat L, Virata M, Gan G, Deng Y, et al.
Clin Lung Cancer
. 2021 Jan;
22(4):e498-e505.
PMID: 33468393
Introduction: This study aimed to compare demographics, disease characteristics, and outcomes of patients with HIV-infection with non-small-cell lung cancer (NSCLC) with the general NSCLC population. Patients And Methods: A retrospective...